Investing Profile

Peter Svennilson

InvestorVCFounder
Managing Partner & Founder at The Column Group
thecolumngroup.com/member/pet...San Francisco, California
Photo of Peter Svennilson, Managing Partner at The Column Group

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
The Column Group Managing Partner
$100K - $5.0M
$1.5M
19
$600M
CompanyStageDateRound SizeTotal Raised
Circle Pharma
Series DSep 2024$90M
Series CJun 2021$66M
Series BMar 2020$45M
$200M
Co-investors: Thilo Schroeder (Nextech Invest), Eric Anschutz
NGM Biopharmaceuticals
Series AJul 2024$120M
Series DMar 2015$58M
Series BMar 2010$55M
Series ADec 2009$27M
$260M
Co-investors: David Goeddel (The Column Group)
Remix Therapeutics
Series UnknownJan 2024$60M
$210M
Co-investors: Kristina Burow (ARCH Venture Partners), Michael Rome (Foresite Capital), Kevin Bitterman (Atlas Venture), Leon Chen (The Column Group)
Carmot Therapeutics
Series EMay 2023$150M
Series DJul 2022$160M
Series CSep 2020$47M
Series BJan 2018$15M
Series UnknownJul 2012$500K
Series AApr 2010$2M
$370M
Co-investors: Derek DiRocco (RA Capital), Zachary Hargreaves
Gritstone bio
Series BSep 2017$93M
Series AOct 2015$100M
$320M
Co-investors: Anthony Philippakis (GV (Google Ventures)), Tom Woiwode (Versant Ventures)
Aragon Pharmaceuticals
Series DOct 2012$50M
Series BApr 2010$22M
Series AMay 2009$8M
$80M
Co-investors: Carl Gordon (OrbiMed), Josh Bilenker (Aisling Capital), Brett Zbar (General Atlantic)